Who to call at Ellipses Pharma Limited, and when
Fundz watches for the moments Ellipses Pharma Limited starts buying, and tells you who to reach.
- An alert the day Ellipses Pharma Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ellipses Pharma Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ellipses Pharma Limited. With Fundz connected, it knows.
Contract Type
agreement
Description
Ellipses Pharma Limited has agreed to in-license global rights to 'GENA-104', a first-in-class immuno-oncology monoclonal antibody targeting CNTN4, a recently discovered checkpoint protein highly expressed in a wide range of tumor types. This agreement aims to accelerate the development of a novel immuno-oncology treatment strategy.
Quick answer
Ellipses In-Licences 'GENA-104' for Developing Next-Generation Immuno-Oncology Drug (February 11, 2025). Ellipses Pharma Limited is based in United Arab Emirates.
- What agreement did Ellipses Pharma Limited announce on February 11, 2025?
- Ellipses Pharma Limited has agreed to in-license global rights to 'GENA-104', a first-in-class immuno-oncology monoclonal antibody targeting CNTN4, a recently discovered checkpoint protein highly expressed in a wide range of tumor types. This agreement aims to accelerate the development of a novel immuno-oncology treatment strategy.
- What does Ellipses Pharma Limited do?
- Ellipses Pharma Limited is a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model.
- Where is Ellipses Pharma Limited based?
- Ellipses Pharma Limited is based in United Arab Emirates.
Source: Fundz verified event record.
Related People
Ellipses Pharma Limited signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.